Mohammed Issa, MD
Pain Medicine · Jamaica Plain, MANPI 1871793661
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (44.3%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Medtronic accounts for 80.7% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $2,377, 8.0 times the $296 reported in 2019.
Across 88 payments — averaging $67.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Boston Scientific$339
- Nevro Corp.$221
- Biotronik NRO, Inc.$147
- SPR Therapeutics, Inc$142
- MML US, Inc.$126
- plus $163 from 5 others
What the payments were for
- Consulting fees$1,00017%
- Travel & lodging$2,28739%
- Food & beverage$2,61144%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 58 | $4,760 |
| Boston Scientific | 14 | $339 |
| Nevro Corp. | 6 | $221 |
| Biotronik NRO, Inc. | 1 | $147 |
| SPR Therapeutics, Inc | 1 | $142 |
| MML US, Inc. | 1 | $126 |
| Abbott | 2 | $66 |
| Bioventus LLC | 2 | $64 |
| AbbVie | 1 | $17 |
| Orexo US, Inc. | 1 | $11 |
| Vertos Medical, Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS$1,324
- INTELLIS ADAPTIVESTIM$964
- Prospera$147
- Senza Spinal Cord Stimulation System$145
- INCEPTIV$142
- SPRINT PNS System$142
- VANTA ADAPTIVESTIM$135
- ReActiv8$126
How this compares
$5,898 in reported general payments places this provider in the 75th percentile of 137 pain medicine providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 29 | $23,517 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 44 | $4,769 |
| Celecoxib | 26 | $2,929 |
| Lidocaine | 29 | $2,558 |
| Gabapentin | 131 | $2,412 |
| Pregabalin | 95 | $2,241 |
| Tizanidine Hcl | 74 | $1,260 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 19 | $899 |
| Cyclobenzaprine Hcl | 39 | $857 |
| Baclofen | 22 | $536 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 11 | $478 |
| Methadone Hcl | 35 | $425 |
| Buprenorphine Hcl | 13 | $373 |
| Topiramate | 20 | $290 |
| Duloxetine Hcl | 14 | $274 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Jamaica Plain
- Hariharan SundramNewton$1.7M
- Thomas SimopoulosBoston$181K
- Ivan UritsWareham$70K
- Antje BarreveldNewton$64K
- Arti OriBoston$62K
- Christine SangBoston$56K
- Ali EbrahimiBurlington$41K
- Alexandra AdlerLowell$35K
- Eduard VaynbergBoston$32K
- David GarasNatick$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.